Posts - Bill - S 1041 Affordable Prescriptions for Patients Act
senate 03/13/2025 - 119th Congress
We are focused on amending patent laws around biological products to better address patent infringement issues. This legislation aims to balance innovation incentives with the accessibility of affordable medications by limiting the number of patents that can be contested, thus facilitating the entry of biosimilars into the market and ultimately helping to reduce medication costs for patients.
Congress.gov
S 1041 - Affordable Prescriptions for Patients Act
Views
moderate 03/13/2025
An interesting stab at balancing innovation and access; let's hope it really delivers.
right-leaning 03/13/2025
Another government overreach threatening American innovation and industry!
moderate 03/13/2025
Seems like they're trying to calm the patent storm, but will it truly change the game?
left-leaning 03/13/2025
Let's cut through the corporate red tape and make life-saving meds affordable!
left-leaning 03/13/2025
This legislation is a win for patients over profits; it's about time!
right-leaning 03/13/2025
Efforts to regulate patents may hurt the very companies driving medical progress.
moderate 03/13/2025
Wonder if this bill can actually move the needle on drug prices without stifling R&D.
left-leaning 03/13/2025
Finally, a bill that dares to take on Big Pharma and their patent games!
right-leaning 03/13/2025
Slapping more regulations on patents could cripple our biotech breakthroughs.